Cells use multiple mechanisms to regulate their metabolic states depending on changes in 13 their nutrient environment. A well--known example is the response of cells to glucose 14 availability. In S. cerevisiae cells growing in glucose--limited medium, the re--availability of 15 glucose leads to the downregulation of gluconeogenesis, the activation of glycolysis, and 16 robust 'glucose repression'. However, our knowledge of the initial mechanisms mediating 17 this glucose--dependent downregulation of the gluconeogenic transcription factors is 18 incomplete. We used the gluconeogenic transcription factor Rds2 as a candidate with which 19 to discover regulators of early events leading to glucose repression. Here, we identify a 20 novel role for the E3 ubiquitin ligase Pib1 in regulating the stability and degradation of Rds2. 21 Glucose addition to glucose--limited cells results in rapid ubiquitination of Rds2, followed by 22 its proteasomal degradation. Through in vivo and in vitro experiments, we establish Pib1 as 23 a ubiquitin E3 ligase that regulates Rds2 ubiquitination and stability. Notably, this Pib1 24 mediated Rds2 ubiquitination, followed by proteasomal degradation, is specific to the 25 presence of glucose. Pib1 is required for complete glucose repression, and enables cells to 26 optimally grow in competitive environments when glucose becomes re--available. Our 27 results reveal the existence of a Pib1 E3--ubiquitin ligase mediated regulatory program that 28 mediates glucose--repression when glucose availability is restored. 29 30 31 52 where alternate carbon source utilization is repressed (15, 16). Therefore, efficient glucose--53 induced catabolite repression is critical to ensure that upon glucose re--entry, 54 gluconeogenesis is shut down (17-19). The initial responses occur immediately after glucose 55 addition, through rapid changes in intracellular metabolite pools, driven by allosteric 56 regulations and metabolic flux rewiring (20-22). Subsequently, the regulation of proteins 57 that enforce the metabolic state switch, takes place by the interplay of transcriptional, 58 translational, post--transcriptional and post--translational responses (23). Post--translation 59 regulation (by signaling mediated events) allows rapid and dynamic regulation of protein 60 levels and activity in response to a nutrient such as glucose (24). While we have a growing 61 understanding of signaling events controlling cell growth with glucose as a carbon source 62 these enzyme transcripts must themselves be regulated. In yeast, Rds2, Cat8, and Sip4 are 87 the transcription factors that regulate gluconeogenic enzyme transcripts during growth in 88 glucose--limited conditions (1,(40)(41)(42). Although these transcription factors are well studied 89 in cells growing in glucose limitation, how these factors are regulated after glucose becomes 90 available has surprisingly not been addressed ( Figure 1A ). 91 In this study, we sought to identify novel regulators of effective glucose repression, 92 by focusing on the gluconeogenic transcription factors when glucose becomes available. For 93 4 this, we used the gluconeogenic transcription factor Rds2 as a candidate. Here, we discover 94 that Rds2 is rapidly ubiquitinated and proteasomally degraded upon glucose addition. This is 95 mediated by a specific E3 ubiquitin ligase --Pib1, in a glucose--dependent manner. Through in 96 vivo and in vitro studies, we show a direct role of Pib1 in mediating glucose--dependent Rds2 97 ubiquitination and degradation. Finally, Pib1 is required for competitive cell growth upon 98 glucose re--entry. Collectively, our study identifies a novel role for a previously obscure E3 99 ubiquitin ligase, in regulating gluconeogenic shutdown, and thereby facilitating effective 100 glucose repression. More generally, our study exemplifies how E3--ubiquitin ligases can 101 respond to changing nutrients, and serve as 'on' or 'off' switches to regulate cellular 102 metabolic state. 103 104
Introduction
The uptake and utilization of nutrients are essential for cell growth and survival. Multiple 33 metabolic pathways within cells make and break nutrients, and these pathways are tightly 34 regulated depending on nutrient availability (1, 2). Since the nutrient environment of a cell 35 is not constant, particularly for free--living microbes, cells rewire their metabolic pathways 36 depending on the changes in nutrient availability (3) (4) (5) . This ability of cells to rapidly and 37 efficiently switch between different metabolic states is crucial for their survival and is 38 closely coupled to the nutrient sensing machinery (6-8). Therefore, cells integrate multiple 39 strategies to carry out efficient metabolic switching. Uderstanding these strategies are 40 major areas of study. 41 Saccharomyces cerevisiae is an excellent model to understand conserved, general 42 principles of metabolic state switching, due to the ease of controlling its metabolism (by 43 altering nutrients provided), coupled with genetic and biochemical approaches to dissect 44 regulatory mechanisms. A feature of S. cerevisiae metabolism is a preference for glucose as 45 a carbon source, and where cells use fermentative metabolism (De Deken, 1966) . This is the ). Glucose availability, therefore, regulates a variety of cellular responses in yeast (12-50 14). Following glucose limitation, cells switch to a gluconeogenic state where alternate 51 carbon sources are utilized, and upon glucose re--entry, cells switch back to a glycolytic state (25) (26) (27) , several gaps remain in our understanding of the 'off--switches' that enable effective 63 glucose repression in cells. 64 In particular, we have a limited understanding of how regulated protein turnover 65 controls metabolic state switching when cells encounter a new nutrient source. Our 66 understanding of regulatory events in this condition is biased towards 'classic' signaling, 67 through the activation of nutrient--responsive kinases and phosphatases (28) (29) (30) . Alternate 68 modes of regulation, including selective protein turnover in response to changing nutrients 69 (as opposed to 'starvation') remain poorly studied. The ubiquitin--mediated proteasomal 70 degradation is a major pathway of selective protein degradation in eukaryotes (31, 32), but 71 the role of the ubiquitin--proteasomal system in regulating metabolic switching is poorly 72 understood. Since target specificity of ubiquitination is achieved by E3 ubiquitin ligases, 73 which bind and specifically target proteins for ubiquitin conjugation (33, 34), there must be 74 distinct E3 ligases activated by unique nutrient cues, which then ubiquitinate their 75 substrates. However, only a few studies identify roles of E3 ubiquitin ligases in the context 76 of glucose--mediated metabolic switching. In yeast, upon glucose depletion, the E3 ligase 77 Grr1 targets the phosphofructokinase (Pfk27) enzyme for degradation, thereby inhibiting 78 glycolysis (35). In the context of catabolite (glucose) repression, the E3 ligase complex 79 SCF Ucc1 regulates the degradation of the citrate synthase enzyme Cit2, thereby inhibiting the 80 glyoxylate shunt (36). Further, the GID complex degrades the gluconeogenic enzymes Fbp1 81 and Pck1, in the presence of glucose (Santt et al., 2008; Schork et al., 2002) . Apart from 82 these, little is known about the role of E3 ligases in regulating effective gluconeogenic 83 shutdown. Similar examples from mammalian cells are even rarer (39). Notably, these 84 studies are limited to only the regulation of relevant metabolic enzymes following glucose 85 addition. For a complete metabolic state switch, the transcription factors which regulate 86 amount of Rds2 protein was similar to that of the control (cells grown in 2% glucose 124 medium). Further, no changes in Rds2 amounts were observed when glucose was not added 125 ( Figure 1C ), reiterating that the change in Rds2 protein was glucose dependent. Overall, 126 these results suggest that glucose addition activates a regulatory event that rapidly reduces 127 the amount of Rds2 in cells. predicted to be ubiquitinated. We found that multiple lysine residues on Rds2 were strongly 142 predicted to be likely ubiquitination sites (Figure  2A,  Supplementary  figure  1A) . To test the 143 possibility that Rds2 might indeed be ubiquitinated and degraded proteasomally, we first 144 investigated if Rds2 was degraded by the proteasome. We treated cells with a proteasomal 145 inhibitor--MG132, and monitored Rds2 protein amounts post glucose addition. Notably, Rds2 146 amounts remained constant after glucose addition ( Figure  2B and Figure  2C ), in contrast to 147 our earlier observations in cells without MG132 (shown in Figure 1 ). This strongly suggested 148 that glucose addition results in the proteasomal degradation of Rds2. We therefore asked 149 whether Rds2 is conditionally ubiquitinated in response to glucose. For this, we added 150 glucose to cells in the presence of MG132, immunopurified Rds2, and probed for poly--151 ubiquitin conjugates (by Western blotting). We observed ubiquitin conjugates only in Rds2 152 immunoprecipitates from glucose treated cells, but not in the control cells where glucose 153 6 was not added ( Figure 2D ). This suggests that Rds2 is specifically ubiquitinated rapidly in 154 cells, in a glucose dependent manner. Collectively these data indicate that Rds2 is 155 ubiquitinated and proteasomally degraded when glucose becomes available in the medium. 156 
157
The E3 ubiquitin ligase Pib1 interacts with and ubiquitinates Rds2. 158 Ubiquitination is a multi--step process mediated by the coordinated action of three enzymes--159 E1 (ubiquitin activating), E2 (ubiquitin conjugating) and E3 (ubiquitin ligase). Ubiquitination 160 substrate specificity depends on the E3 ubiquitin ligase, which selectively binds to and 161 ubiquitinates the target protein (33). Therefore we hypothesized that in the presence of 162 glucose, an unidentified E3 ubiquitin ligase should specifically ubiquitinate Rds2 and 163 regulate its degradation ( Figure 3A ). We used YeastMine (47) to identify known interacting 164 proteins of Rds2. This revealed, Pib1, a protein with E3 ligase activity, as an interacting 165 protein partner of Rds2 (as seen in other high--throughput studies (48)). This putative 166 interaction and possible regulatory function of Pib1 and Rds2 have remained unexplored. 167 Therefore, to directly probe this putative interaction, we performed co--168 immunoprecipitation studies by immunopurified Pib1 (endogenously tagged at the carboxy--169 terminus with an HA epitope tag) and tested whether Rds2 associated with immunopurified 170 Pib1. Notably, we performed these experiments using cells grown in (i) glucose--limited 171 medium (2% glycerol and ethanol as a carbon source), (ii) without the addition of glucose, or 172 (iii) 20 minutes after glucose addition. Strikingly, we observed a strong co--173 immunopurification of Rds2 with Pib1, only when Pib1 was isolated from cells minutes after 174 glucose addition to the medium ( Figure 3B ). This strongly suggested that Pib1 interacts with 175 Rds2, and specifically when glucose became available in the medium ( Figure 3B ). 176 These data, therefore, suggested a possible involvement of Pib1 in regulating Pib1 ubiquitinates Rds2 in vitro. 190 In order to determine if Pib1 can directly act as an E3 ligase that ubiquitinates Rds2, we 191 reconstituted an in vitro ubiquitination assay system. This assay requires incubating the 192 substrate protein (Rds2), ATP and ubiquitin with purified E1, E2 and E3 enzymes in a suitable 193 reaction buffer, followed by western blotting with anti--ubiquitin antibody to detect 194 ubiquitin conjugates of the substrate ( Figure 4A ). S. cerevisiae has a single E1 ubiquitin--195 activating enzyme--Uba1 (49). We also utilized the E2 ubiquitin--conjugating enzyme Ubc4, 196 since it has been used as an E2 ligase with Pib1 in a previous study (50). We first expressed 197 recombinant Uba1 and Ubc4 (with C--terminal GST tags) in E.coli, and subsequently purified 198 these proteins ( Figure  4B ). These proteins were then utilized in predetermined amounts in 199 the in vitro assay. Separately, we immunoprecipitated Rds2 (substrate) from pib1Δ cells, and Figure 4C ), robust Rds2--ubiquitin conjugates were observed 204 exclusively when the E1, E2, Pib1 and ubiquitin (along with ATP) were present in the 205 reaction mixture ( Figure 4C ). Pib1 did not ubiquitinate the control protein (BSA) in these 206 conditions, and the E1 and E2 enzymes alone could not ubiquitinate Rds2 ( Figure 4C ). These 207 data show that Pib1 specifically, directly ubiquitinates Rds2 in vitro. Finally, in order to 208 understand the glucose specificity of this process, we performed this in vitro ubiquitination 209 assay using Rds2 (substrate) immunopurified from cells growing in glucose--limited 210 conditions, with or without glucose addition for ~20 minutes. Notably, no Rds2--ubiquitin 211 conjugates were observed with Rds2 immunoprecipitated from cells withtout glucose 212 addition, while clear poly--ubiquitination was observed in Rds2 immunopurified from cells 213 post glucose--addition ( Figure 4D ). This confirms that Pib1 mediated Rds2 ubiquitination is 214 glucose dependent. Collectively, these data establish Pib1 as the E3 ubiquitin ligase that 215 ubiquitinates Rds2 upon glucose re--availability, leading to Rds2 degradation. 216 217 Pib1 mediates the effective shutdown of gluconeogenesis following glucose addition. 218 If Pib1 is important for overall adaptation of cells to the presence of glucose (i.e. glucose 219 repression), cells lacking Pib1 could be expected to show some defects in fully shutting 220 down gluconeogenesis, after glucose re--entry. Therefore, since Rds2 transcriptionally 221 activates the gluconeogenic enzyme genes --FBP1 and PCK1, cells lacking Pib1 may 222 accumulate these transcripts after glucose addition. To test this, we first estimated 223 transcript levels of these genes in WT and pib1Δ cells at different time points after glucose 224 addition by qRT--PCR. We observed significantly higher mRNA levels of both FBP1 and PCK1 225 in pib1Δ cells one hour post glucose addition, compared to the WT cells ( Figure 5A) . Finally, 226 we tested the functional implications of the loss of Pib1, and inefficient shutting down of 227 the gluconeogenic machinery (after glucose addition), using a competitive growth fitness 228 assay with WT and pib1Δ cells. WT and pib1Δ cells (carrying different drug selection 229 markers) were grown separately in glucose--replete, or glucose--limited medium, and equal 230 numbers of these cells (based on absorbance at OD 600 ) were mixed together in either 231 glucose--replete or glucose--limited medium. Cells were plated on drug selection plates at 232 different time intervals, and the relative number of WT and pib1Δ were calculated by colony 233 counting. This experimental design is illustrated in Figure 4B . Under conditions when cells 234 are transferred from glucose poor to glucose replete medium, the pib1Δ cells will not as 235 efficiently switch to glycolysis (i.e. show efficient glucose repression) as WT cells, predicting 236 that WT cells will outcompete pib1Δ cells in growth. Indeed, we observed that the relative 237 number of WT cells is higher compared to pib1Δ cells after the switch to a glucose--replete 238 medium, for around 4.5 hours ( Figure 4B ). Eventually, over longer times, the pib1Δ cells 239 catch up with the WT cells. Note: in control experiments (where the cells were grown and 240 mixed in glucose--replete medium), both WT and pib1Δ cells showed equal numbers of cells 241 ( Figure 4B ). Also interestingly, when cells were grown and mixed together in glucose--242 deficient (glycerol/ethanol) medium, pib1Δ cells outcompeted WT cells around 6 hours after cells were shifted to this medium ( Figure 4B ), further supporting a role for Pib1 in regulating 244 a gluconeogenic state. Collectively, these data suggest that Pib1 regulates the ability of cells 245 to efficiently switch to a glucose--repressed state, by controlling the amounts of the 246 gluconeogenic regulator Rds2, upon glucose re--entry. In this study, we identify a functional role for the E3 ubiquitin ligase Pib1, as a mediator of 250 effective gluconeogenic shutdown upon glucose re--entry into the medium. Pib1 binds to 251 and mediates the glucose--dependent ubiquitination, and subsequent proteasomal 252 degradation of the gluconeogenic transcription factor Rds2. Competitive growth 253 experiments suggest a role for Pib1 in mediating effective glucose repression, suggesting a 254 role for Pib1 in mediating an 'off--switch' for gluconeogenesis. 255 We first characterized glucose--mediated Rds2 regulation, and using this as our presented. Data are displayed as means ± SD, n=3. *p<0.05, **p0.01, ***p<0.001. 
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